Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
Pfizer will charge $3.5M for its first FDA-approved gene therapy
Pfizer has gained its first FDA approval for a gene therapy, scoring with Beqvez for hemophilia B and will charge $3.5M for the one-time therapy.
Kevin Dunleavy
Apr 26, 2024 10:19am
GSK launches mRNA patent infringement case against Pfizer
Apr 26, 2024 10:04am
Sponsored
MAIC Methodology Matters: Comparing BRUKINSA vs Acalabrutinib in R/R CLL
Apr 1, 2024 8:00am
Head-to-head, it's AbbVie's Rinvoq over Regeneron's Dupixent
Apr 26, 2024 7:39am
Sponsored
The biopharma “brain drain”: Finding talent to fuel innovation
Jan 26, 2024 8:00am
Takeda joins growing list of drugmakers to leave trade group BIO
Apr 26, 2024 7:25am